As the complexity of drug development increases, researchers need quantitative systems pharmacology (QSP) models that incorporate virtual populations and can capture data spanning numerous clinical trials. However, appropriate implementation of these trials requires consideration of distinct therapeutic modalities and targets, as well as precise representation of clinical protocols. Few modeling platforms are able to cleanly meet these needs—but Thales is designed to do just that. In this webinar, Dr. Ryan Suderman, Director of QSP at Simulations Plus, will walk you through the Thales QSP modeling platform and show you how it can streamline integration of your clinical information.

You will learn how to use Thales’ standardized objects to manage progression of virtual patients through various stages of disease and easily specify clinical protocols. You will also see how the Thales platform makes it straightforward to integrate diverse clinical data at all points during disease progression. Once the various clinical protocols and data have been added, Thales’ universal optimization tools provide a powerful mechanism to reconcile these data within a single virtual population that will readily support clinical project timelines.

The research and regulatory requirements are complex, but your QSP modeling can be streamlined. Register to join us and learn how.

Presenters:

• Dr. Ryan Suderman – Director of QSP